Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	JADE1 CREBBP KAT2B	8.47e-05	15	117	3	GO:0010484
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DYNC2H1 DNAH2 DNAH17	1.50e-04	18	117	3	GO:0008569
GeneOntologyCellularComponent	protein acetyltransferase complex	NAA15 JADE1 CREBBP KAT2B PHF20L1 ACTL9	2.26e-05	104	114	6	GO:0031248
GeneOntologyCellularComponent	acetyltransferase complex	NAA15 JADE1 CREBBP KAT2B PHF20L1 ACTL9	2.96e-05	109	114	6	GO:1902493
GeneOntologyCellularComponent	histone acetyltransferase complex	JADE1 CREBBP KAT2B PHF20L1 ACTL9	1.65e-04	94	114	5	GO:0000123
GeneOntologyCellularComponent	anchoring junction	HSPG2 MYADM CNKSR1 CALR ITGA3 KCNA1 PTPRJ PRKCG CLMP PRKD1 CDH5 CDH10 CDH11 ADGRL3 SYMPK	2.71e-04	976	114	15	GO:0070161
GeneOntologyCellularComponent	outer kinetochore	CREBBP BUB1 KNL1	2.94e-04	24	114	3	GO:0000940
GeneOntologyCellularComponent	plasma membrane protein complex	HSPG2 CATSPERE HLA-DRB4 CATSPER3 ITGA3 RET CHRNE KCNA1 LRP6 CACNG5 CDH5 CDH10 CDH11	3.52e-04	785	114	13	GO:0098797
GeneOntologyCellularComponent	cell-cell junction	MYADM CNKSR1 PTPRJ PRKCG CLMP PRKD1 CDH5 CDH10 CDH11 ADGRL3 SYMPK	3.90e-04	591	114	11	GO:0005911
GeneOntologyCellularComponent	catenin complex	CDH5 CDH10 CDH11	6.98e-04	32	114	3	GO:0016342
Domain	Calcineurin-like_Pesterase	MPPED2 MPPED1	3.56e-05	2	112	2	IPR024201
Domain	Gal_mutarotase_SF_dom	MAN2C1 BEST4 MGAM2	1.34e-04	17	112	3	IPR011013
Domain	Mtc	SFXN1 SFXN3	3.52e-04	5	112	2	PF03820
Domain	Mtc	SFXN1 SFXN3	3.52e-04	5	112	2	IPR004686
Domain	Cadherin_C	CDH5 CDH10 CDH11	4.39e-04	25	112	3	PF01049
Domain	Cadherin_cytoplasmic-dom	CDH5 CDH10 CDH11	4.39e-04	25	112	3	IPR000233
Domain	Metallophos	SMPDL3B MPPED2 MPPED1	6.17e-04	28	112	3	PF00149
Domain	Calcineurin-like_PHP_ApaH	SMPDL3B MPPED2 MPPED1	6.17e-04	28	112	3	IPR004843
Domain	Catenin_binding_dom	CDH5 CDH10 CDH11	6.85e-04	29	112	3	IPR027397
Domain	-	CDH5 CDH10 CDH11	6.85e-04	29	112	3	4.10.900.10
Domain	Metallo-depent_PP-like	SMPDL3B MPPED2 MPPED1	7.57e-04	30	112	3	IPR029052
Domain	-	SMPDL3B MPPED2 MPPED1	7.57e-04	30	112	3	3.60.21.10
Domain	DHC_N1	DYNC2H1 DNAH2	9.75e-04	8	112	2	PF08385
Domain	Dynein_heavy_dom-1	DYNC2H1 DNAH2	9.75e-04	8	112	2	IPR013594
Domain	LDLR_class-A_CS	HSPG2 LRP1B LRP6	1.76e-03	40	112	3	IPR023415
Domain	Rossmann-like_a/b/a_fold	ASNSD1 PAPSS1 CRY2	2.18e-03	43	112	3	IPR014729
Domain	-	ASNSD1 PAPSS1 CRY2	2.18e-03	43	112	3	3.40.50.620
Domain	Ldl_recept_a	HSPG2 LRP1B LRP6	2.48e-03	45	112	3	PF00057
Domain	-	HSPG2 LRP1B LRP6	2.64e-03	46	112	3	4.10.400.10
Domain	OLF	OLFML2A ADGRL3	2.66e-03	13	112	2	PF02191
Domain	OLF	OLFML2A ADGRL3	2.66e-03	13	112	2	PS51132
Domain	Olfac-like_dom	OLFML2A ADGRL3	2.66e-03	13	112	2	IPR003112
Domain	OLF	OLFML2A ADGRL3	2.66e-03	13	112	2	SM00284
Domain	LDLRA_1	HSPG2 LRP1B LRP6	2.98e-03	48	112	3	PS01209
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH2	3.09e-03	14	112	2	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DNAH2	3.09e-03	14	112	2	IPR024743
Domain	Dynein_heavy_dom-2	DYNC2H1 DNAH2	3.09e-03	14	112	2	IPR013602
Domain	DHC_N2	DYNC2H1 DNAH2	3.09e-03	14	112	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DNAH2	3.09e-03	14	112	2	IPR011704
Domain	MT	DYNC2H1 DNAH2	3.09e-03	14	112	2	PF12777
Domain	AAA_8	DYNC2H1 DNAH2	3.09e-03	14	112	2	PF12780
Domain	Ldl_recept_b	LRP1B LRP6	3.09e-03	14	112	2	PF00058
Domain	LDLRB	LRP1B LRP6	3.09e-03	14	112	2	PS51120
Domain	AAA_5	DYNC2H1 DNAH2	3.09e-03	14	112	2	PF07728
Domain	LDrepeatLR_classA_rpt	HSPG2 LRP1B LRP6	3.16e-03	49	112	3	IPR002172
Domain	LDLa	HSPG2 LRP1B LRP6	3.16e-03	49	112	3	SM00192
Domain	LDLRA_2	HSPG2 LRP1B LRP6	3.16e-03	49	112	3	PS50068
Domain	DHC_fam	DYNC2H1 DNAH2	3.56e-03	15	112	2	IPR026983
Domain	Dynein_heavy	DYNC2H1 DNAH2	3.56e-03	15	112	2	PF03028
Domain	LY	LRP1B LRP6	3.56e-03	15	112	2	SM00135
Domain	Dynein_heavy_dom	DYNC2H1 DNAH2	3.56e-03	15	112	2	IPR004273
Domain	LDLR_classB_rpt	LRP1B LRP6	3.56e-03	15	112	2	IPR000033
Domain	NAP_family	TSPYL6 TSPYL4	4.57e-03	17	112	2	IPR002164
Domain	NAP	TSPYL6 TSPYL4	4.57e-03	17	112	2	PF00956
Domain	Cadherin	RET CDH5 CDH10 CDH11	4.78e-03	113	112	4	PF00028
Domain	CADHERIN_2	RET CDH5 CDH10 CDH11	4.93e-03	114	112	4	PS50268
Domain	-	RET CDH5 CDH10 CDH11	4.93e-03	114	112	4	2.60.40.60
Domain	CA	RET CDH5 CDH10 CDH11	5.09e-03	115	112	4	SM00112
Domain	Cadherin-like	RET CDH5 CDH10 CDH11	5.24e-03	116	112	4	IPR015919
Domain	Cadherin	RET CDH5 CDH10 CDH11	5.57e-03	118	112	4	IPR002126
Pubmed	HIV-1 tat protein and cell proliferation and survival: a brief review.	CDK9 CREBBP KAT2B	3.69e-07	5	117	3	16035254
Pubmed	HIV-1 infection and regulation of Tat function in macrophages.	CDK9 CREBBP KAT2B	3.69e-07	5	117	3	15183343
Pubmed	The multiple functions of HIV-1 Tat: proliferation versus apoptosis.	CDK9 CREBBP KAT2B	3.69e-07	5	117	3	16146763
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	CDK9 NRDE2 MYH8 REPS1 HSPA4L ZNF189 CHD1 RET CREBBP GTF2F2 NKAPD1 BUB1 PRKD1 KNL1	2.42e-06	910	117	14	36736316
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	GTPBP4 NAA15 CENPC ESYT1 CHD1 NSUN2 CREBBP SFXN1 TBCB EEF1G NAMPT PSME4 PIK3C2A CEBPZ SFXN3 EIF3A TOP2B	2.94e-06	1353	117	17	29467282
Pubmed	Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue.	CDH5 CDH10 CDH11	4.38e-06	10	117	3	2059658
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	GTPBP4 HSPA4L DYNC2H1 CALR ESYT1 CHD1 IDE NSUN2 SFXN1 EEF1G NAMPT CEBPZ SFXN3 EIF3A HNRNPLL TOP2B MGAM2	5.83e-06	1425	117	17	30948266
Pubmed	Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.	CREBBP CRY2 KAT2B	7.98e-06	12	117	3	14645221
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CDK9 GTPBP4 CENPC CHD1 PAPSS1 NSUN2 CREBBP EEF1G GTF2F2 NAMPT EIF3A HNRNPLL TOP2B SYMPK	8.32e-06	1014	117	14	32416067
Pubmed	Individual functions of the histone acetyl transferases CBP and p300 in regulating the inflammatory response of synovial fibroblasts.	CREBBP KAT2B	1.12e-05	2	117	2	34304080
Pubmed	In vitro interaction of a polypeptide homologous to human Ro/SS-A antigen (calreticulin) with a highly conserved amino acid sequence in the cytoplasmic domain of integrin alpha subunits.	CALR ITGA3	1.12e-05	2	117	2	1911778
Pubmed	Correlation of metabolic syndrome with serum omentin-1 and visfatin levels and disease severity in psoriasis and psoriatic arthritis.	ITLN1 NAMPT	1.12e-05	2	117	2	33029930
Pubmed	Cell attachment to extracellular matrix substrates is inhibited upon downregulation of expression of calreticulin, an intracellular integrin alpha-subunit-binding protein.	CALR ITGA3	1.12e-05	2	117	2	8006073
Pubmed	Calreticulin is directly involved in anti-alpha3 integrin antibody-mediated secretion and activation of matrix metalloprotease-2.	CALR ITGA3	1.12e-05	2	117	2	11327697
Pubmed	Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for androgen-regulated gene expression in advanced prostate cancer cells.	CREBBP KAT2B	1.12e-05	2	117	2	22174411
Pubmed	cDNA sequence, genomic organization, and evolutionary conservation of a novel gene from the WAGR region.	MPPED2 MPPED1	1.12e-05	2	117	2	8666403
Pubmed	Effect of KNL1 on the proliferation and apoptosis of colorectal cancer cells.	BUB1 KNL1	1.12e-05	2	117	2	31315522
Pubmed	The crystal structure of the N-terminal region of BUB1 provides insight into the mechanism of BUB1 recruitment to kinetochores.	BUB1 KNL1	1.12e-05	2	117	2	19141287
Pubmed	The involvement of aryl hydrocarbon receptor in the activation of transforming growth factor-beta and apoptosis.	CREBBP KAT2B	1.12e-05	2	117	2	9687573
Pubmed	p27 Nuclear localization and growth arrest caused by perlecan knockdown in human endothelial cells.	CDKN1B HSPG2	1.12e-05	2	117	2	20074558
Pubmed	The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers.	CDKN1B EIF3A	1.12e-05	2	117	2	24789280
Pubmed	The 239AB gene on chromosome 22: a novel member of an ancient gene family.	MPPED2 MPPED1	1.12e-05	2	117	2	9266672
Pubmed	Role of adipokines (omentin and visfatin) in coronary artery disease.	ITLN1 NAMPT	1.12e-05	2	117	2	36653284
Pubmed	Omentin and visfatin in adolescent inpatients with anorexia nervosa; association with symptoms.	ITLN1 NAMPT	1.12e-05	2	117	2	33626391
Pubmed	Serum Levels of Visfatin, Omentin and Irisin in Patients with End-Stage Lung Disease Before and After Lung Transplantation.	ITLN1 NAMPT	1.12e-05	2	117	2	29277835
Pubmed	PCAF regulates the stability of the transcriptional regulator and cyclin-dependent kinase inhibitor p27 Kip1.	CDKN1B KAT2B	1.12e-05	2	117	2	22547391
Pubmed	Expression and regulation of INTELECTIN1 in human granulosa-lutein cells: role in IGF-1-induced steroidogenesis through NAMPT.	ITLN1 NAMPT	1.12e-05	2	117	2	24943040
Pubmed	Site-specific detection and structural characterization of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion.	LCAT APOD	1.12e-05	2	117	2	7613477
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	HSPG2 MYADM GALNT2 HSPA4L CALR ESYT1 ITGA3 LRP1B HIF1AN OLFML2A PTPRJ LRP6 EIF3A IGSF3 SYMPK	1.27e-05	1201	117	15	35696571
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DYNC2H1 DNAH2 DNAH17	1.31e-05	14	117	3	9373155
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GTPBP4 NAA15 REPS1 ESYT1 CHD1 NSUN2 TBCB EEF1G GTF2F2 NAMPT EIF3A TOP2B KNL1	1.64e-05	934	117	13	33916271
Pubmed	Cadherin expression in the developing mouse olfactory system.	CDH5 CDH10 CDH11	2.01e-05	16	117	3	17278136
Pubmed	Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.	CDK9 CREBBP KAT2B	2.44e-05	17	117	3	11547919
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	CDK9 GTPBP4 CENPC ESYT1 CHD1 NSUN2 SFXN1 EEF1G CEBPZ EIF3A TOP2B KNL1 SYMPK	2.98e-05	989	117	13	36424410
Pubmed	Is periodontal inflamed surface area associated with serum and salivary levels of IL-1β, visfatin, and omentin-1 in overweight/obese patients?	ITLN1 NAMPT	3.36e-05	3	117	2	35451654
Pubmed	Regulation of the homeodomain CCAAT displacement/cut protein function by histone acetyltransferases p300/CREB-binding protein (CBP)-associated factor and CBP.	CREBBP KAT2B	3.36e-05	3	117	2	10852958
Pubmed	Sequential multisite phospho-regulation of KNL1-BUB3 interfaces at mitotic kinetochores.	BUB1 KNL1	3.36e-05	3	117	2	25661489
Pubmed	Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.	CREBBP KAT2B	3.36e-05	3	117	2	11607033
Pubmed	A new paradigm in eukaryotic biology: HIV Tat and the control of transcriptional elongation.	CDK9 KAT2B	3.36e-05	3	117	2	15719065
Pubmed	NSun2 delays replicative senescence by repressing p27 (KIP1) translation and elevating CDK1 translation.	CDKN1B NSUN2	3.36e-05	3	117	2	26687548
Pubmed	LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea.	LCAT APOD	3.36e-05	3	117	2	31779197
Pubmed	Phosphoregulation of the titin-cap protein telethonin in cardiac myocytes.	PIK3C2A PRKD1	3.36e-05	3	117	2	24280220
Pubmed	Structural analysis reveals features of the spindle checkpoint kinase Bub1-kinetochore subunit Knl1 interaction.	BUB1 KNL1	3.36e-05	3	117	2	22331848
Pubmed	Association of serum Interleukin-10, omentin-1 and visfatin concentration with metabolic risk factors in obese children.	ITLN1 NAMPT	3.36e-05	3	117	2	31235138
Pubmed	Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription.	CDK9 KAT2B	3.36e-05	3	117	2	18250157
Pubmed	Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor gamma.	CREBBP KAT2B	3.36e-05	3	117	2	11884404
Pubmed	Transcriptional stimulation by hepatocyte nuclear factor-6. Target-specific recruitment of either CREB-binding protein (CBP) or p300/CBP-associated factor (p/CAF).	CREBBP KAT2B	3.36e-05	3	117	2	10811635
Pubmed	Decoding Tat: the biology of HIV Tat posttranslational modifications.	CREBBP KAT2B	3.36e-05	3	117	2	16046164
Pubmed	Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.	ITLN1 NAMPT	3.36e-05	3	117	2	25453978
Pubmed	p27Kip1, PCAF and PAX5 cooperate in the transcriptional regulation of specific target genes.	CDKN1B KAT2B	3.36e-05	3	117	2	28158851
Pubmed	MPS1/Mph1 phosphorylates the kinetochore protein KNL1/Spc7 to recruit SAC components.	BUB1 KNL1	3.36e-05	3	117	2	22660415
Pubmed	A review of HIV-1 Tat protein biological effects.	CDK9 CREBBP	3.36e-05	3	117	2	15473004
Pubmed	E1A directly binds and regulates the P/CAF acetyltransferase.	CREBBP KAT2B	3.36e-05	3	117	2	9687513
Pubmed	Placental expressions and serum levels of adiponectin, visfatin, and omentin in GDM.	ITLN1 NAMPT	3.36e-05	3	117	2	31076892
Pubmed	Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinical parameters.	ITLN1 NAMPT	3.36e-05	3	117	2	20823688
Pubmed	Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes.	CREBBP KAT2B	3.36e-05	3	117	2	11046145
Pubmed	Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300.	CREBBP KAT2B	3.36e-05	3	117	2	18400184
Pubmed	Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP.	CREBBP KAT2B	3.36e-05	3	117	2	10673499
Pubmed	Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.	CDKN1B RET	3.36e-05	3	117	2	18316595
Pubmed	In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.	CREBBP KAT2B	3.36e-05	3	117	2	33894414
Pubmed	Systematic in vivo structure-function analysis of p300 in hematopoiesis.	CREBBP KAT2B	3.36e-05	3	117	2	19822904
Pubmed	eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation.	CDKN1B EIF3A	3.36e-05	3	117	2	26213845
Pubmed	Circulating levels of novel adipocytokines in patients with colorectal cancer.	ITLN1 NAMPT	3.36e-05	3	117	2	23474107
Pubmed	Analysis of three functional polymorphisms in relation to osteoporosis phenotypes: replication in a Spanish cohort.	LCT LRP6	3.36e-05	3	117	2	20390408
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	CDKN1B NAA15 CENPC CALR IDE PAPSS1 NSUN2 CRY2 KIN PHF20L1 BUB1 EIF3A TOP2B KNL1	3.51e-05	1155	117	14	20360068
Pubmed	E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.	CDH5 CDH10 CDH11	4.06e-05	20	117	3	7806582
Pubmed	Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-alpha, and -epsilon and -zeta isoforms in PC12 cells.	PIK3C2A PRKCG PRKD1	4.72e-05	21	117	3	9446795
Pubmed	HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes.	PIK3C2A PRKCG PRKD1	5.45e-05	22	117	3	11154208
Pubmed	Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments.	PTPRJ CDH5	6.70e-05	4	117	2	16893970
Pubmed	Adenovirus DNA binding protein interacts with the SNF2-related CBP activator protein (SrCap) and inhibits SrCap-mediated transcription.	CREBBP KAT2B	6.70e-05	4	117	2	11581372
Pubmed	Differential roles of p300 and PCAF acetyltransferases in muscle differentiation.	CREBBP KAT2B	6.70e-05	4	117	2	9659901
Pubmed	ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis.	CDKN1B WWP2	6.70e-05	4	117	2	31430374
Pubmed	p300/CBP-associated factor drives DEK into interchromatin granule clusters.	CREBBP KAT2B	6.70e-05	4	117	2	15987677
Pubmed	Interaction between acetylated MyoD and the bromodomain of CBP and/or p300.	CREBBP KAT2B	6.70e-05	4	117	2	11463815
Pubmed	HIV-1 TAR RNA: the target of molecular interactions between the virus and its host.	CDK9 CREBBP	6.70e-05	4	117	2	15638724
Pubmed	Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities.	CREBBP KAT2B	6.70e-05	4	117	2	12297501
Pubmed	KLF8 recruits the p300 and PCAF co-activators to its amino terminal activation domain to activate transcription.	CREBBP KAT2B	6.70e-05	4	117	2	20107328
Pubmed	Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome.	CREBBP KAT2B	6.70e-05	4	117	2	9809067
Pubmed	Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions.	CDK9 CREBBP	6.70e-05	4	117	2	15139295
Pubmed	The histone acetyltransferases CBP/p300 are degraded in NIH 3T3 cells by activation of Ras signalling pathway.	CREBBP KAT2B	6.70e-05	4	117	2	16704373
Pubmed	Functional interaction between coactivators CBP/p300, PCAF, and transcription factor FKLF2.	CREBBP KAT2B	6.70e-05	4	117	2	11748222
Pubmed	CREB-binding protein/p300 activates MyoD by acetylation.	CREBBP KAT2B	6.70e-05	4	117	2	10944526
Pubmed	Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).	CREBBP KAT2B	6.70e-05	4	117	2	16537920
Pubmed	Direct involvement of CREB-binding protein/p300 in sequence-specific DNA binding of virus-activated interferon regulatory factor-3 holocomplex.	CREBBP KAT2B	6.70e-05	4	117	2	11940575
Pubmed	Circulating adipokines and mRNA expression in adipose tissue and the placenta in women with gestational diabetes mellitus.	ITLN1 NAMPT	6.70e-05	4	117	2	29337272
Pubmed	Regulation of ERK1 gene expression by coactivator proteins.	CREBBP KAT2B	6.70e-05	4	117	2	16050810
Pubmed	HNF1beta/TCF2 mutations impair transactivation potential through altered co-regulator recruitment.	CREBBP KAT2B	6.70e-05	4	117	2	15509593
Pubmed	Mapping of the gene for calreticulin (Calr) to mouse chromosome 8.	CALR LCAT	6.70e-05	4	117	2	9337407
Pubmed	Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells.	PTPRJ CDH5	6.70e-05	4	117	2	22246030
Pubmed	Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.	PTPRJ CDH5	6.70e-05	4	117	2	12771128
Pubmed	Defining the molecular basis of BubR1 kinetochore interactions and APC/C-CDC20 inhibition.	BUB1 KNL1	6.70e-05	4	117	2	20220147
Pubmed	Regulation of E2A activities by histone acetyltransferases in B lymphocyte development.	CREBBP KAT2B	6.70e-05	4	117	2	12435739
Pubmed	A sequential multi-target Mps1 phosphorylation cascade promotes spindle checkpoint signaling.	BUB1 KNL1	6.70e-05	4	117	2	28072388
Pubmed	Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency.	CDKN1B CREBBP	6.70e-05	4	117	2	14998493
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	CDK9 GTPBP4 REPS1 HSPA4L WWP2 PAPSS1 NSUN2 SFXN1 TBCB EEF1G SMPDL3B PIK3C2A CEBPZ HNRNPLL	7.97e-05	1247	117	14	27684187
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	CDK9 GTPBP4 MYADM NAA15 KRT16 ESYT1 NSUN2 SFXN1 EEF1G GTF2F2 KIN KLHL7 CEBPZ EIF3A	8.67e-05	1257	117	14	36526897
Pubmed	The transcription factor c-Maf controls touch receptor development and function.	RET CRYGS KCNA1	1.02e-04	27	117	3	22345400
Pubmed	Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis.	CREBBP KAT2B	1.11e-04	5	117	2	15023334
Pubmed	Defining the molecular basis of interaction between R3 receptor-type protein tyrosine phosphatases and VE-cadherin.	PTPRJ CDH5	1.11e-04	5	117	2	28926625
Pubmed	Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation.	CREBBP KAT2B	1.11e-04	5	117	2	21131905
Cytoband	10p15-p14	GTPBP4 KIN	9.60e-05	6	117	2	10p15-p14
Cytoband	3p24	KAT2B TOP2B	1.79e-04	8	117	2	3p24
Cytoband	2p16.2	TSPYL6 PSME4	2.29e-04	9	117	2	2p16.2
GeneFamily	CD molecules\|Type II classical cadherins	CDH5 CDH10 CDH11	1.90e-05	13	75	3	1186
GeneFamily	Sideroflexins	SFXN1 SFXN3	1.68e-04	5	75	2	746
GeneFamily	Low density lipoprotein receptors	LRP1B LRP6	1.29e-03	13	75	2	634
GeneFamily	Dyneins, axonemal	DNAH2 DNAH17	2.22e-03	17	75	2	536
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	CREBBP KAT2B	2.22e-03	17	75	2	486
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT15 GALNT2	3.07e-03	20	75	2	433
Coexpression	GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS	GALNT15 DYNC2H1 LCAT APOD OLFML2A FRY PPP1R16B CLMP CDH5 CDH11 ADGRL3	1.43e-05	505	115	11	M39167
Coexpression	KARLSSON_TGFB1_TARGETS_UP	GTPBP4 NAA15 JADE1 NSUN2 GTF2F2 EIF3A	1.75e-05	123	115	6	M2080
Coexpression	KARLSSON_TGFB1_TARGETS_UP	GTPBP4 NAA15 JADE1 NSUN2 GTF2F2 EIF3A	2.10e-05	127	115	6	MM1289
Coexpression	GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN	TMEM243 CHD1 IDE JADE1 PSME4 CEBPZ ACTR6	2.52e-05	195	115	7	M9508
Coexpression	GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP	CDKN1B HSPG2 LCAT LCT CREBBP GFM2 LRP6	2.87e-05	199	115	7	M3641
Coexpression	GSE18893_TCONV_VS_TREG_2H_CULTURE_DN	HIF1AN KAT2B NAMPT PIK3C2A SUSD2 ETNK1 TSPYL4	2.96e-05	200	115	7	M7293
ToppCell	E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	WWP2 CPE PAPSS1 PLEKHG1 CLMP MPPED2 IGSF3	6.32e-07	188	116	7	9b95730ddd13eb4624321bab3ab4989414977ca3
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT15 HSPG2 PLEKHG1 OLFML2A PIK3C2A PPP1R16B CDH5	7.80e-07	194	116	7	74a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	APOD LRP1B OPHN1 KAT2B CACNG5 TSPYL4 CDH10	9.24e-07	199	116	7	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	APOD LRP1B OPHN1 KAT2B LRP6 CACNG5 CDH10	9.24e-07	199	116	7	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	APOD LRP1B OPHN1 KAT2B CACNG5 TSPYL4 CDH10	9.24e-07	199	116	7	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DYNC2H1 NTNG1 CLMP PRKD1 ARHGAP20 CDH10 CDH11	9.56e-07	200	116	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NTNG1 CATSPER3 APOD CLMP CDH11 IGSF3	5.42e-06	169	116	6	031465190cd3623a25ef2b868daab8d932c8ff08
ToppCell	5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 PLEKHG1 MGAT3 PPP1R16B CDH5 CDH10	5.80e-06	171	116	6	b3e6e31dfe3623b960ccf692fdbd236fa4039923
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT15 HSPG2 PLEKHG1 PIK3C2A MPPED2 CDH5	7.53e-06	179	116	6	1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT15 HSPG2 PLEKHG1 MGAT3 PPP1R16B CDH5	7.53e-06	179	116	6	8f9e538c822940785130297712b75131812a4603
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DYNC2H1 APOD FRY CLMP CDH11 ADGRL3	7.53e-06	179	116	6	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GALNT15 HSPG2 CPE ZNF248 PTPRJ PRKD1	8.02e-06	181	116	6	2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYADM CNKSR1 DNAH2 ZFHX2 PRKCG	9.42e-06	108	116	5	d620f07243c2628494e689bbfabc14c453f4b1f4
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ITGA3 OPHN1 PLEKHG1 FRY CDH5 ADGRL3	1.03e-05	189	116	6	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DYNC2H1 NTNG1 OLFML2A CLMP ARHGAP20 CDH11	1.03e-05	189	116	6	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CALR NTNG1 ITGA3 APOD OLFML2A FRY	1.06e-05	190	116	6	92710caaff05123cf8e909319d7ac441d9b31a66
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	APOD PPP1R16B MYOM2 MPPED2 CDH5 ADGRL3	1.06e-05	190	116	6	106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTNG1 CLMP PRKD1 ARHGAP20 CDH10 CDH11	1.06e-05	190	116	6	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	DYNC2H1 JADE1 APOD OPHN1 CLMP ADGRL3	1.09e-05	191	116	6	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	GALNT15 DYNC2H1 JADE1 APOD OPHN1 CLMP	1.12e-05	192	116	6	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	WWP2 CPE LRP1B PLEKHG1 MPPED2 ADGRL3	1.12e-05	192	116	6	d0649410cf5eacdb0c1dce70e37c7473ef5fddfa
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPA4L APOD PLEKHG1 PPP1R16B CDH5 ADGRL3	1.12e-05	192	116	6	0aeb5351275c0a91151ea2d52b2cdde172da6731
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTNG1 CLMP PRKD1 ARHGAP20 CDH10 CDH11	1.12e-05	192	116	6	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTNG1 CLMP PRKD1 ARHGAP20 CDH10 CDH11	1.16e-05	193	116	6	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	IPF-Epithelial-Mesothelial\|Epithelial / Disease state, Lineage and Cell class	GALNT15 ITLN1 NTNG1 CPE NAMPT CDH11	1.19e-05	194	116	6	d8a26da856a85e3d001d406e992cb18fdd58baef
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTNG1 CLMP PRKD1 ARHGAP20 CDH10 CDH11	1.19e-05	194	116	6	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	GALNT15 HSPG2 PLEKHG1 PPP1R16B PRKD1 CDH5	1.26e-05	196	116	6	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CDK9 RET CHRNE KCNA1 SMPDL3B PRKCG	1.26e-05	196	116	6	95544097577f20ed7f4144bd940471cde0617554
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT15 HSPG2 PLEKHG1 PIK3C2A PPP1R16B CDH5	1.26e-05	196	116	6	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT15 HSPG2 PLEKHG1 PIK3C2A PPP1R16B CDH5	1.26e-05	196	116	6	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DYNC2H1 NTNG1 CLMP ARHGAP20 CDH10 CDH11	1.38e-05	199	116	6	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DYNC2H1 NTNG1 CLMP PRKD1 ARHGAP20 CDH11	1.38e-05	199	116	6	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NTNG1 CATSPER3 ITGA3 APOD OLFML2A	5.04e-05	153	116	5	c1335e7d7407412431ed4d8c7dfcb2c6086d8483
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPA4L ZNF189 TSPYL4 IGSF3 SYMPK	5.70e-05	157	116	5	f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCell	lung-Type_I_Pneumocytes\|lung / shred on tissue and cell subclass	PLEKHG1 SUSD2 BEST4 LRP6	6.28e-05	82	116	4	6023212a51f8b3e05e6c3dcf4e8fbf53ba696fb2
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HSPG2 ZNF248 SMPDL3B CDH5 KNL1	6.81e-05	163	116	5	3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DYNC2H1 CLMP ARHGAP20 CDH11 ADGRL3	8.07e-05	169	116	5	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SFXN1 EEF1G BEST4 PPP1R16B HNRNPLL	8.30e-05	170	116	5	adb625124832b0786a590e8f75b61e7263a1e0d4
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NTNG1 APOD CLMP CDH11 IGSF3	8.53e-05	171	116	5	15cb4670ff4234ac46aea8a5911138d6913c4482
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 DNAH2 KCNA1 BEST4 DLEC1	9.01e-05	173	116	5	c3762655caa79ac4879876f470d32578a3c93b01
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM243 PTPRJ PRKCG CLMP CDH11	9.01e-05	173	116	5	e944ea3a0a368f856efacbda4600605cf751dd9c
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM243 PTPRJ PRKCG CLMP CDH11	9.01e-05	173	116	5	85fa5918e9c1f6bb4757e3350cfc71ee75c55640
ToppCell	wk_08-11-Mesenchymal-Chondrocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	WWP2 CPE PLEKHG1 KCNA1 MPPED2	9.77e-05	176	116	5	1af28b701c4598ce761f85adbd5d79e4918d265a
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GALNT15 HSPG2 NTNG1 APOD KCNA1	1.00e-04	177	116	5	6b4fe717928814dafcd13090b1c90ea973938c6d
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GALNT15 HSPG2 BUB1 CDH5 KNL1	1.03e-04	178	116	5	ea10117026021c959ffc871fc377cdb3e161d264
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HSPG2 FRY PRKD1 CDH5 CDH11	1.06e-04	179	116	5	d2db9e70b780643f1e004c41a70464d0abe26088
ToppCell	Control-Endothelial_cells-Capillary_endothelial_cells\|Control / group, cell type (main and fine annotations)	LRP1B OPHN1 PLEKHG1 CDH5 ADGRL3	1.09e-04	180	116	5	b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HSPG2 NTNG1 OLFML2A KCNA1 MPPED2	1.14e-04	182	116	5	a1c0e4090a9e7aa4941a40c817d178de144888b6
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FA2H NTNG1 APOD KAT2B CACNG5	1.14e-04	182	116	5	3cc61f5f7ad4a81eba3daf65e122880b5af3adc0
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Macroglial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H KCNA1 CACNG5 CDH10 ADGRL3	1.14e-04	182	116	5	82ca6d5ed48b4c487ce00b9309255abb8f20b61d
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FA2H NTNG1 APOD KAT2B CACNG5	1.14e-04	182	116	5	5d909e4b5f662905bf1be9c686bbddc3e87d2be9
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH8 LCT OLFML2A ARHGAP20 CDH11	1.17e-04	183	116	5	ebe369dc80c4fbf8f4dbe947147f8c47507ffb60
ToppCell	droplet-Heart-4Chambers-21m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPE PLEKHG1 PPP1R16B CDH5 CDH11	1.20e-04	184	116	5	f17d713af4a97dff4eeeab24c405677ef2ffcf84
ToppCell	metastatic_Brain-Endothelial_cells-Stalk-like_ECs\|metastatic_Brain / Location, Cell class and cell subclass	GALNT15 HSPG2 FRY ARHGAP20 CDH5	1.23e-04	185	116	5	ad52970e88e8947ef256095bd4b40229b912d58a
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPA4L APOD PLEKHG1 CDH5 ADGRL3	1.23e-04	185	116	5	808d5e880069aff8866cd2c733b9fe568a37701f
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT15 MYH8 APOD CLMP ADGRL3	1.23e-04	185	116	5	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	Control-Epithelial-Mesothelial\|Epithelial / Disease state, Lineage and Cell class	GALNT15 ITLN1 NTNG1 CPE CDH11	1.23e-04	185	116	5	0af540323c0113203ba6c1a4cb32d2fb9cf79d39
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPE ITGA3 KCNA1 MYOM2 CDH11	1.23e-04	185	116	5	872720275789d249c9859de825a923803d458875
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GALNT15 RET APOD PPP1R16B CDH5	1.23e-04	185	116	5	3be9e05b929ac4d956b1d53284072f668a6c1959
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CPE ITGA3 FRY PRKCG MPPED2	1.23e-04	185	116	5	11fbea1eb1d9a3e4480d0d2b0f7b02e2866b8142
ToppCell	PBMC-Control-cDC_10\|Control / Compartment, Disease Groups and Clusters	PLEKHG1 MGAT3 CLMP PRKD1 IGSF3	1.23e-04	185	116	5	4b5a7450fed912f340da16065c1e65d626dbe8d1
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-lymphatic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GALNT15 RET APOD PPP1R16B CDH5	1.23e-04	185	116	5	c3dd64a726cb8a1fe048683c266b7532a714a52e
ToppCell	343B-Fibroblasts-Fibroblast-E-\|343B / Donor, Lineage, Cell class and subclass (all cells)	GALNT15 CPE APOD CLMP ARHGAP20	1.27e-04	186	116	5	1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f
ToppCell	(0)_MSCs\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	APOD SUSD2 CLMP CDH11 IGSF3	1.27e-04	186	116	5	a832c1e0035bcd559722eccf262c145deb3494c7
ToppCell	343B-Fibroblasts-Fibroblast-E\|343B / Donor, Lineage, Cell class and subclass (all cells)	GALNT15 CPE APOD CLMP ARHGAP20	1.27e-04	186	116	5	59db239f1864a5d4f1570c93219dbd7ac5b6db35
ToppCell	(0)_MSCs-(00)_Lepr-MSC\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	APOD SUSD2 CLMP CDH11 IGSF3	1.27e-04	186	116	5	f0d156167d7cc2cd8a76e5a364233e9f2170bc01
ToppCell	droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NTNG1 CPE MGAT3 KCNA1 IGSF3	1.30e-04	187	116	5	6f7f293c9cf35261e0e3614e46ec1fb00a701b63
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	NTNG1 OLFML2A CLMP ARHGAP20 CDH11	1.30e-04	187	116	5	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	DYNC2H1 CPE SUSD2 CLMP CDH11	1.33e-04	188	116	5	116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H KCNA1 CACNG5 CDH10 ADGRL3	1.33e-04	188	116	5	c2101ded71fb16b8ddbc1f883911b1ed2a533ffc
ToppCell	COPD-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	ITGA3 OPHN1 PLEKHG1 FRY CDH5	1.33e-04	188	116	5	1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NTNG1 ITGA3 APOD FRY CDH10	1.33e-04	188	116	5	9db778c1d9e622a68337212296e3a1ed8f771fa5
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FA2H KCNA1 CACNG5 CDH10 ADGRL3	1.33e-04	188	116	5	3b8b9161f0fdcbde302ce5b4c0bc874628211109
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 APOD OLFML2A CDH5 ALOX12	1.33e-04	188	116	5	26915db8863f4115b46a81982e187322e21600fd
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 OLFML2A CLMP PRKD1 CDH11	1.33e-04	188	116	5	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 APOD OLFML2A CDH5 ALOX12	1.33e-04	188	116	5	3f76c0f912f8f023ea425be7f43593b3d7f967e3
ToppCell	RA-11._Adipocyte\|World / Chamber and Cluster_Paper	KRT16 LRP1B NAMPT CLMP ARHGAP20	1.33e-04	188	116	5	4dac9d636e5cad4cda540b93d4bfed6b5732c880
ToppCell	Endothelial-A-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	HSPG2 TEX13D PLEKHG1 CDH5 CDH11	1.33e-04	188	116	5	0824d567356d360fd8e78e840c30529c139f98a1
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 APOD OLFML2A CDH5 ALOX12	1.33e-04	188	116	5	61ee7b152745164293d8a44ef91ee2393efbdca5
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NTNG1 ITGA3 APOD FRY CDH10	1.33e-04	188	116	5	047c4e0b03fc8334e38c48977e41d26dbe229d47
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT15 CPE PLEKHG1 PIK3C2A PPP1R16B	1.36e-04	189	116	5	c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCell	RA-14._Fibroblast_III\|RA / Chamber and Cluster_Paper	GALNT2 CHD1 CPE NAMPT CLMP	1.36e-04	189	116	5	46e9a58aacd79db5a02898a8c7244e1884adcfd1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTNG1 CLMP PRKD1 ARHGAP20 CDH11	1.36e-04	189	116	5	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	RA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	GALNT2 CHD1 CPE NAMPT CLMP	1.36e-04	189	116	5	b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 PLEKHG1 PPP1R16B MPPED2 CDH5	1.36e-04	189	116	5	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	moderate-Epithelial-Ionocyte\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	JADE1 RET CHRNE SMPDL3B ADGRL3	1.36e-04	189	116	5	6011b747e27d61d222380a7bffdd921a68e9b657
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT15 HSPG2 PLEKHG1 PPP1R16B CDH5	1.36e-04	189	116	5	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	HSPG2 PLEKHG1 NAMPT PIK3C2A CDH11	1.36e-04	189	116	5	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GALNT15 HSPG2 CPE PLEKHG1 CDH5	1.36e-04	189	116	5	fccadf8efbef17b7f12291b069c71060a71b04e2
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CENPC NTNG1 BUB1 CDH11 KNL1	1.36e-04	189	116	5	d049f33115610bda4489968759f754730698b9cd
ToppCell	moderate-Lymphoid-NK\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	HSPG2 CPE CLMP CDH5 CDH11	1.36e-04	189	116	5	22a19365782003c18ec8dddcdbfdaa82c4e330f6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT15 PLEKHG1 PIK3C2A PPP1R16B CDH5	1.40e-04	190	116	5	656483751e4bf137e4e4bfb2a03a478a8f7fcb63
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GALNT15 HSPG2 PLEKHG1 BUB1 KNL1	1.40e-04	190	116	5	31de1727822e9818652946dfb962daee77ffad68
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CPE APOD NAMPT CLMP CDH11	1.43e-04	191	116	5	f5ce33af56178333730be308253943c54a0724cf
ToppCell	COVID-19-kidney-vSMC/Pericyte\|kidney / Disease (COVID-19 only), tissue and cell type	KRT16 CPE FRY MYOM2 ADGRL3	1.43e-04	191	116	5	fad8eaa536001b911d05ae2b12150c2398cc6f88
ToppCell	metastatic_Lymph_Node-Fibroblasts-Myofibroblasts\|metastatic_Lymph_Node / Location, Cell class and cell subclass	GALNT15 HSPG2 APOD CLMP CDH11	1.43e-04	191	116	5	aa43b472bc8362f79ae63f09f1ca764718bbf22c
ToppCell	(12)_SLC16A7+\|World / shred by cell type by condition	DNAH2 ZNF713 BEST4 CLMP DLEC1	1.43e-04	191	116	5	e427eeddd2e87c14376a37db0b43f120c90436bc
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	HSPG2 PLEKHG1 PIK3C2A PPP1R16B CDH5	1.43e-04	191	116	5	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NTNG1 CLMP PRKD1 ARHGAP20 CDH11	1.47e-04	192	116	5	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GALNT15 HSPG2 PLEKHG1 PPP1R16B MPPED2	1.47e-04	192	116	5	27ff3621e177e7932dd44dd6baa81551ea75a874
Drug	afimoxifene	CDK9 CDKN1B FA2H DNAH2 RET APOD PAPSS1 PSME4 ETNK1 CDH11 TOP2B IGSF3 SYMPK	8.45e-07	479	114	13	ctd:C016601
Disease	Colorectal Neoplasms	CALR NTNG1 CHD1 RET SFXN1 NAMPT BUB1 PRKD1 CDH5	1.27e-06	277	113	9	C0009404
Disease	Multiple Endocrine Neoplasia	CDKN1B RET	4.35e-05	3	113	2	C0027662
Disease	Colorectal Carcinoma	CALR NTNG1 CHD1 CPE RET SFXN1 NAMPT BUB1 PRKD1 ACTL9 CDH5	8.26e-05	702	113	11	C0009402
Disease	pheochromocytoma (implicated_via_orthology)	CDKN1B RET	8.68e-05	4	113	2	DOID:0050771 (implicated_via_orthology)
Disease	Postural instability	NTNG1 SFXN1 MPPED2	1.18e-04	25	113	3	HP_0002172
Disease	selenium measurement	DMGDH DYNC2H1 MYOM2	1.86e-04	29	113	3	EFO_0006331
Disease	phenol sulfate measurement	PLEKHG1 PRKD1	4.01e-04	8	113	2	EFO_0021011
Disease	Prostatic Intraepithelial Neoplasias	CDKN1B TOP2B	7.82e-04	11	113	2	C0282612
Disease	lung adenocarcinoma (is_implicated_in)	CALR LRP1B PTPRJ	8.86e-04	49	113	3	DOID:3910 (is_implicated_in)
Disease	Carcinoma, Neuroendocrine	CDKN1B RET	9.36e-04	12	113	2	C0206695
Disease	acute myeloid leukemia (implicated_via_orthology)	CREBBP TOP2B	9.36e-04	12	113	2	DOID:9119 (implicated_via_orthology)
Disease	proto-oncogene tyrosine-protein kinase receptor Ret measurement	RET ZNF248	1.10e-03	13	113	2	EFO_0008272
Disease	Neurodegeneration with brain iron accumulation	REPS1 FA2H	1.10e-03	13	113	2	cv:C2931845
Disease	Paranoid Schizophrenia	CALR HLA-DRB4	1.10e-03	13	113	2	C0036349
Disease	Carcinoma of Endocrine Gland	CDKN1B RET	1.48e-03	15	113	2	C1704374
Disease	primary autosomal recessive microcephaly (is_implicated_in)	BUB1 KNL1	1.68e-03	16	113	2	DOID:0070296 (is_implicated_in)
Disease	carotid artery intima media thickness	CDKN1B GALNT2 DYNC2H1 CPE LRP1B DUSP22 DLEC1	1.77e-03	450	113	7	EFO_0007117
Disease	type 2 diabetes mellitus (is_marker_for)	APOD NAMPT PIK3C2A ALOX12	1.89e-03	136	113	4	DOID:9352 (is_marker_for)
Disease	venous thromboembolism	MYH8 FA2H SFXN1 OLFML2A PTPRJ DLEC1 CDH11	2.00e-03	460	113	7	EFO_0004286
Disease	Profound Mental Retardation	CNKSR1 NAA15 FRY PRKCG	2.04e-03	139	113	4	C0020796
Disease	Mental Retardation, Psychosocial	CNKSR1 NAA15 FRY PRKCG	2.04e-03	139	113	4	C0025363
Disease	Mental deficiency	CNKSR1 NAA15 FRY PRKCG	2.04e-03	139	113	4	C0917816
Disease	carotid artery disease (is_marker_for)	HSPG2 NAMPT	2.38e-03	19	113	2	DOID:3407 (is_marker_for)
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	CDKN1B PTPRJ	2.38e-03	19	113	2	C1333991
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	CDKN1B PTPRJ	2.38e-03	19	113	2	C2936783
Disease	Bipolar Disorder	CALR HLA-DRB4 NTNG1 APOD CRY2 CACNG5 ALOX12	2.45e-03	477	113	7	C0005586
Disease	end stage renal disease (implicated_via_orthology)	GTPBP4 LCAT	2.64e-03	20	113	2	DOID:783 (implicated_via_orthology)
Disease	albumin:globulin ratio measurement	REPS1 GALNT2 DUSP22	2.80e-03	73	113	3	EFO_0005128
Disease	epilepsy (implicated_via_orthology)	ITGA3 LRP1B KCNA1 ETNK1	3.62e-03	163	113	4	DOID:1826 (implicated_via_orthology)
Disease	pulmonary hypertension (biomarker_via_orthology)	CDKN1B NAMPT CDH5	3.63e-03	80	113	3	DOID:6432 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
YQNLPPAEKDQYWDE	BEST4	341	Q8NFU0
NFDVNKYLGRWYEIE	APOD	36	P05090
YILPFQKGYLVNWDV	ACTR6	56	Q9GZN1
ERIIQYYGPATWAED	ERV3-1	486	Q14264
PLGQVKLTLWYYSEE	ESYT1	971	Q9BSJ8
QSYKGNDPLGEWERY	BUB1	16	O43683
PINYWKNGYNLLDVI	CATSPER3	106	Q86XQ3
QPSKNLRVRYIWGEY	CATSPERE	736	Q5SY80
PLWNPNKEYEDLLDY	CEP68	291	Q76N32
DYKYLRWQVVDTPGI	GTPBP4	211	Q9BZE4
AVDYNPRDNLLYVWN	ADGRL3	366	Q9HAR2
CWVLREQYEEQGPYI	ACTL9	396	Q8TC94
KLDTGQYQEPWQYVD	CREBBP	1141	Q92793
EDYYETENPKGQWLL	C13orf42	301	A0A1B0GVH6
KQGALYWEPEALYTL	BTBD11	456	A6QL63
WQEVEKGSLPEFYYR	CDKN1B	76	P46527
KELDREVYPWYNLTV	CDH5	431	P33151
RWLKNASPEDVEYYN	CHD1	361	O14646
IGIDWQDYRLNYSKD	CHRNE	76	Q04844
YWQLPETYQGDKVAA	HSPG2	1396	P98160
RNDNDSWDYTKPYLG	HNRNPLL	251	Q8WVV9
PTIEGYLYTQEKWAL	OPHN1	266	O60890
DETPKGWYIQYIDRD	KIN	131	O60870
YYQELKIVPEGEWGQ	NSUN2	51	Q08J23
DWLGNLPYEYKIVIA	MPPED2	101	Q15777
EYWPSKQAQDYGDIT	PTPRJ	1151	Q12913
NPGYYDIQAKDLGIW	ITLN1	136	Q8WWA0
DLRWEKYAGEQGLQY	PRKD1	866	Q15139
EKEYQRQVWLLFEYP	KCNA1	146	Q09470
WPNGISIDYEENKLY	LRP1B	2041	Q9NZR2
YEPYNNGSLKRVWIL	MGAM2	416	Q2M2H8
PRWGDYEDKRDLNYI	MGAT3	441	Q09327
PNDDISGYKENYTRW	KAT2B	271	Q92831
YPALKWDLEYLQENI	HIF1AN	71	Q9NWT6
GTPRWELEYQLTEAY	SMPDL3B	351	Q92485
WSIDELPSKQGYYLQ	KIAA1109	3071	Q2LD37
FKWYLENVYPELRVP	GALNT2	426	Q10471
QYYPSKDLQRGVLDW	GALNT15	321	Q8N3T1
EPGVLYNLKERYAAW	MYH8	101	P13535
WQDLLVGAPYYFERK	ITGA3	321	P26006
LAEWLRKYNPSEEEY	PIK3C2A	1211	O00443
AGPEALRWLQLYIYK	HAO1	121	Q9UJM8
PANWEYKSLYRGDIA	NRDE2	171	Q9H7Z3
WKNRIYNSPIYGADI	KDM4D	126	Q6B0I6
DWYQRQRPSEIKDYS	KRT16	151	P08779
LLNWIKEEYGDIPIY	LCT	1256	P09848
IYWPNGLTLDYEEQK	LRP6	181	O75581
DYDPLDKQLYWIDSR	LRP6	971	O75581
EEIEYLKRWGPNYNL	KNL1	2241	Q8NG31
VLWPLYQFDEKYGGQ	MYADM	256	Q96S97
PQAIIYNLWFGYDVK	GGTLC2	131	Q14390
QVYDAAVRWLKYDEP	KLHL7	206	Q8IXQ5
VDGWYKLLNQEEGEY	PRKCG	271	P05129
RNEQLDWPYEYLKPS	ALOX12	641	P18054
FNEWLGSLPYEYKIV	MPPED1	131	O15442
QERNPENWAYYKGLE	NAA15	251	Q9BXJ9
NLYRKEYEGEAILWQ	PPP1R16B	356	Q96T49
WLEQYYVGELRGEQQ	FA2H	76	Q7L5A8
RVYWNDGLDQYRLTP	PAPSS1	386	O43252
KLGTLNLWEDPYYLV	DYNC2H1	266	Q8NCM8
ERRNYIPQGWTKFYE	DYNC2H1	3876	Q8NCM8
DYWLYLEEGVIVPQN	CACNG5	31	Q9UF02
PNYAWYKLAEEVSGR	IGSF3	791	O75054
RYIYEPWNAPESIQK	CRY2	461	Q49AN0
LYNYLEANPKVPWDD	DNAH17	4066	Q9UFH2
QYVVPEVKDLYNWLE	EIF3A	381	Q14152
NYDYLREWGPRFNKL	CDH10	761	Q9Y6N8
KPLEYWRGERIDYQG	CENPC	746	Q03188
EYPEYQRWMGLNDRL	CRYGS	66	P22914
KVLEGVWIFYELPNY	CRYGS	131	P22914
YKGEWKPRQIDNPDY	CALR	271	P27797
KDGDYWRLLIPGNYK	CPE	406	P16870
DLDYDYLQNWGPRFK	CDH11	766	P55287
YQAVTELGRPDAEYW	HLA-DRB4	76	P13762
YRQWLKEEYGESPLQ	DUSP22	146	Q9NRW4
ELDPNRYGKWTTTQY	DMGDH	426	Q9UI17
QQLEWVKSRYPGLYS	MAN2C1	301	Q9NTJ4
LYPWKYISRENIIEE	ASNSD1	196	Q9NWL6
APYDWRLEPGQQEEY	LCAT	166	P04180
RTEEWYGTQYKQEAI	IDE	491	P14735
QVDYESYTWRKLDPG	EEF1G	391	P26641
GLSPDGYLYKWLDNI	FRY	1176	Q5TBA9
DYSLYPDRELQSQWL	ETNK1	356	Q9HBU6
EVWPNVDNYELYEKL	CDK9	251	P50750
ELEVENGAWSYLPVY	DLEC1	946	Q9Y238
DLEPYVAQYSGKARW	DNAH2	536	Q9P225
LLRPGGKWYDLEYSN	CEBPZ	176	Q03701
IDYNPKERVLYAWDN	OLFML2A	626	Q68BL7
GARLEALDYLQKWYP	PHF20L1	16	A8MW92
ILEKSLDYGRTWQPY	NTNG1	161	Q9Y2I2
DYQLWVNSGKEEAPY	ARHGAP20	241	Q9P2F6
NTWELKPEYRHYQGE	GTF2F2	231	P13984
EKSELVNETRWQYYG	SUSD2	156	Q9UGT4
SPEERNYEFLQWYKD	GFM2	351	Q969S9
GITEDQLWRAKYVYD	SFXN3	61	Q9BWM7
DDPWKITDEQRQYYV	REPS1	276	Q96D71
PGLTENELWRAKYIY	SFXN1	61	Q9H9B4
YDDNQRVEPEWYIPI	TOP2B	851	Q02880
RYPKDELNWGRLNYI	TDRD9	681	Q8NDG6
WNYILEKYDGHLPIE	NAMPT	101	P43490
RLPEEVVDFLYQYWK	JADE1	441	Q6IE81
PIVYYWQRIREKEGE	CLMP	161	Q9H6B4
LYWYRQPQDEKAEGL	CNKSR1	436	Q969H4
EESQRYYWRPKNEIS	NKAPD1	66	Q6ZUT1
YYWRPKNEISGTLED	NKAPD1	71	Q6ZUT1
CILIYWYRQGDLEPK	TMEM243	76	Q9BU79
EEWDYLDPAQRSLYK	ZNF189	26	O75820
APLWYQRSYIQEEDS	TEX13D	281	A0A0J9YY54
WEQRELPNGRVYYVD	WWP2	306	O00308
KYESWGPLYIQESGE	ZSCAN21	171	Q9Y5A6
PEQLEILYRWYMQDS	ZFHX2	1866	Q9C0A1
WLYEDGEDQPKQVYV	HSPA4L	661	O95757
YWIGVRYDEPLGKND	TBCB	191	Q99426
EIIKGELWPNPLQYY	TSPYL4	371	Q9UJ04
RLATDNIGYIDWDPY	PSME4	261	Q14997
PYIQYNVLWEEGKAA	SYMPK	221	Q92797
YWEKLYVDQAAGTPL	RET	36	P07949
LQLLGDADQEKYTYW	TEX13A	246	Q9BXU3
EDLWSNPLQYYLLGE	TSPYL6	371	Q8N831
WDQLYPAQKNLYRDV	ZNF713	46	Q8N859
PYNDSDKLNDYLWRG	PLEKHG1	1346	Q9ULL1
EWYLLDPAQKILYRD	ZNF248	21	Q8NDW4
QWDRPKHEEDLLGYY	MYOM2	631	P54296